Analysis of Antiangiogenic Potential and Cell Death Mechanism of a Kinetically Inert Platinum Antitumor Agent-Reference-Cited by-同舟云学术

Analysis of Antiangiogenic Potential and Cell Death Mechanism of a Kinetically Inert Platinum Antitumor Agent

Published:2024-08-19 Issue: Volume: Page:
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

M Manikandan¹^ORCID,Chhatar Sushanta¹,Dey Saurabh²,Panda Tushar Ranjan¹,Chakraborty Sourav³⁴,Ray Pritha³⁴,Patra Chinmoy²,Patra Malay¹^ORCID

Affiliation:

1. Medicinal Chemistry and Cell Biology Laboratory, Department of Chemical Sciences, Tata Institute of Fundamental Research, Homi Bhabha Road, Mumbai, Maharashtra 400005, India

2. Department of Developmental Biology, Agharkar Research Institute, G G Agarkar Road, Pune, 411004 Maharashtra, India

3. Imaging Cell Signaling & Therapeutics Lab, Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Tata Memorial Centre, Sector 22, Kharghar, Navi Mumbai, Maharashtra 410210, India

4. Homi Bhabha National Institute, second floor, BARC Training School Complex, Anushaktinagar, Mumbai, Maharashtra 400094, India

Funder

Department of Atomic Energy, Government of India

Tata Institute of Fundamental Research

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.4c00207

Reference38 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

3. A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research

4. The rediscovery of platinum-based cancer therapy

5. The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents